Latest Stories
Graham Corporation (NYSE:GHM) Reports Bullish Q4 CY2025
Industrial fluid and energy systems manufacturer Graham Corporation (NYSE: GHM) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 20.5% year on year to $56.7 million. The company expects the full year’s revenue to be around $236 million, close to analysts’ estimates. Its non-GAAP profit of $0.31 per share was 69.1% above analysts’ consensus estimates.
Centene (NYSE:CNC) Surprises With Q4 CY2025 Sales
Health coverage company Centene (NYSE:CNC) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 21.9% year on year to $49.73 billion. On the other hand, the company’s full-year revenue guidance of $188.5 billion at the midpoint came in 2.1% below analysts’ estimates. Its non-GAAP loss of $1.19 per share was 2.5% above analysts’ consensus estimates.
MarketAxess (NASDAQ:MKTX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Electronic bond trading platform MarketAxess (NASDAQ:MKTX) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 3.5% year on year to $209.4 million. Its non-GAAP profit of $1.68 per share was 2.4% above analysts’ consensus estimates.
Proto Labs (NYSE:PRLB) Reports Upbeat Q4 CY2025, Stock Jumps 14.7%
Manufacturing services provider Proto Labs (NYSE:PRLB) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 12.1% year on year to $136.5 million. Guidance for next quarter’s revenue was better than expected at $134 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $0.44 per share was 27.9% above analysts’ consensus estimates.
RXO (NYSE:RXO) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops
Freight Delivery Company RXO (NYSE:RXO) fell short of the markets revenue expectations in Q4 CY2025, with sales falling 11.9% year on year to $1.47 billion. Its non-GAAP loss of $0.07 per share was 67.7% below analysts’ consensus estimates.
MDU Q4 Deep Dive: Regulatory Wins and Data Center Expansion Shape Cautious Outlook
Energy and construction materials company MDU Resources (NYSE:MDU) missed Wall Street’s revenue expectations in Q4 CY2025, with revenue of $534 million. Its GAAP profit of $0.37 per share increased from $0.27 in the same quarter last year.
ROAD Q4 Deep Dive: Acquisitions and Sunbelt Demand Drive Strong Results and Upbeat Outlook
Civil infrastructure company Construction Partners (NASDAQ:ROAD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 44.1% year on year to $809.5 million. The company’s full-year revenue guidance of $3.52 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $0.47 per share was 53.4% above analysts’ consensus estimates.
GFF Q4 Deep Dive: Strategic Portfolio Moves Reshape Core Business
Multi-industry consumer and professional products manufacturer Griffon Corporation (NYSE:GFF) announced better-than-expected revenue in Q4 CY2025, with sales up 2.6% year on year to $649.1 million. On the other hand, the company’s full-year revenue guidance of $1.8 billion at the midpoint came in 28.9% below analysts’ estimates. Its non-GAAP profit of $1.45 per share was 8.9% above analysts’ consensus estimates.
BILL Q4 Deep Dive: AI Investments and Product Expansion Drive Revenue Acceleration
Financial automation platform BILL (NYSE:BILL) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 14.4% year on year to $414.7 million. Guidance for next quarter’s revenue was better than expected at $402.5 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $0.64 per share was 14.2% above analysts’ consensus estimates.
ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion at the midpoint came in 3% above analysts’ estimates. Its non-GAAP profit of $1.35 per share was 8.3% above analysts’ consensus estimates.